← Research library

Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials.

Review of earlier studies · 2017

What was studied
442 participants in the pooled CARS-1 and CARS-2 analysis
Main finding
Individual-participant analysis reports a favorable motor-recovery result during early rehabilitation.

ARAT at day 90 · Mann–Whitney effect size 0.62 · p<0.0001

Reported findings and study design

Individual-patient meta-analysis of CARS-1/2; 442 patients. Cerebrolysin 30 mL/day for three weeks starting 24–72 hours after stroke; standardized 21-day rehabilitation.

Population or model 442 participants in the pooled CARS-1 and CARS-2 analysis

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
ARAT at day 90Mann–Whitney effect size 0.62p<0.0001
Early NIHSS at days 14/21Mann–Whitney effect size 0.59p<0.002
NNT for clinically relevant early NIHSS change7.1; 95% CI 4–22

Combines two trials already represented elsewhere. Mann–Whitney estimates are not percentage improvements; last-observation-carried-forward analysis was used.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Reanalysis of existing trials, not a new independent cohort. The CARS totals already include these participants.

Source details

Journal publication

Citation and indexed abstract checked. Full methods, funding and risk of bias have not been comprehensively appraised.

Sources checked

Citation

ReviewEnglish abstract

Guekht A, Vester J, Heiss WD, Gusev E, Hoemberg V, Rahlfs VW, Bajenaru O, Popescu BO, Doppler E, Winter S, Moessler H, Muresanu D. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Study source ↗ · DOI 10.1007/s10072-017-3037-z · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards